ReviewCancers2021

Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals.

Elisabeth von Guggenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.